primary pulmonary hypertension
Showing 1 - 8 of 8
Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, Systemic Sclerosis Trial in Dresden, Heidelberg (Riociguat Oral
Recruiting
- Pulmonary Vascular Disorder
- +3 more
- Riociguat Oral Tablet
- Placebo
-
Dresden, Germany
- +1 more
Jan 26, 2023
Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo
Recruiting
- Hypertension
- +8 more
- Tamoxifen
- Placebo Oral Tablet
-
Nashville, TennesseeVanderbilt University Medical Center
Aug 22, 2022
Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension, Primary Pulmonary Hypertension Trial in Nashville
Enrolling by invitation
- Pulmonary Arterial Hypertension
- +4 more
- L-carnitine
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 7, 2021
Primary Pulmonary Hypertension Trial in United States (LIQ861 Inhaled Treprostinil)
Active, not recruiting
- Primary Pulmonary Hypertension
- LIQ861 Inhaled Treprostinil
-
Phoenix, Arizona
- +24 more
Aug 26, 2021
Primary Pulmonary Hypertension Trial in United States (LIQ861 Inhaled Treprostinil)
Completed
- Primary Pulmonary Hypertension
- LIQ861 Inhaled Treprostinil
-
Phoenix, Arizona
- +37 more
Nov 5, 2020
Idiopathic Pulmonary Arterial Hypertension, Primary Pulmonary Hypertension, Pulmonary Arterial Hypertension Trial in Tampa
Withdrawn
- Idiopathic Pulmonary Arterial Hypertension
- +3 more
- Diltiazem Hydrochloride
- Sugar Pill
-
Tampa, FloridaUniversity of South Florida
Nov 16, 2018
Interstitial Pulmonary Fibrosis ARDS, COPD (COPD), Bronchiectasis Trial in Seoul (Veno-veno-arterial ECMO)
Completed
- Interstitial Pulmonary Fibrosis ARDS
- +5 more
- Veno-veno-arterial ECMO
-
Seoul, Korea, Republic ofDepartment of Anesthesiology and Pain Medicine, Anesthesia and P
Jul 15, 2018
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative
Terminated
- Primary Myelofibrosis
- +3 more
-
Salt Lake City, Utah
- +1 more
Mar 17, 2016